Cytokinetics reported $-69201000 in EBIT for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Acadia Pharmaceuticals ACAD:US $ -15301000 28.41M
Acceleron Pharma XLRN:US $ -70630000 6.97M
Amgen AMGN:US $ 2378M 45M
Arca Biopharma ABIO:US $ -4102000 2.11M
Bayer BAYN:GR 1.22B 426M
Biogen BIIB:US $ 858.6M 171.5M
Brainstorm Cell Therapeutics BCLI:US $ -5277000 844K
Bristol Myers Squibb BMY:US $ 2985M 18M
Cytokinetics CYTK:US $ -69201000 14.4M
Eisai 4523:JP 5.5B 49.91B
Eli Lilly And LLY:US $ 2055.2M 626.8M
Exelixis EXEL:US $ 51.62M 71.39M
Genocea Biosciences GNCA:US $ -11716000 2.83M
Geron GERN:US $ -25674000 3.22M
Halozyme Therapeutics HALO:US $ 75.59M 17.46M
Intra Cellular Therapies ITCI:US $ -77323830 8.18M
Ligand Pharmaceuticals LGND:US $ 15.71M 30.03M
Merk MRK:US $ 5352M 3083M
Novartis NOVN:VX 3.48B 77M
Pfizer PFE:US $ 9254M 2592M
Regeneron Pharmaceuticals REGN:US $ 1847.2M 1500M